Tracking endogenous and grafted neural progenitor cells in normal and ischaemic brains using MRI contrast agents and genetic labelling

Cerebral ischaemia is a major cause of mortality and morbidity globally. Neural stem and progenitor cells (NPC) have the potential to contribute to brain repair and regeneration after an ischaemic event. Both endogenous and grafted NPC have been shown to migrate towards the ischaemic lesion, and differentiate into neurons. This thesis investigates methods of labeling and tracking the migration neural progenitor cells to a site of cerebral ischaemic injury, using magnetic resonance imaging (MRI) contrast agents and transgenic lineage tracing techniques. First, labeling of exogenous NPC populations was investigated, for use in cell tracking in grafting studies. Cell labeling was optimized in vitro with fetal NPC using the iron oxide-based MRI contrast agent. A labeling method was developed using the FePro contrast agent, which maximized iron oxide uptake, was non-toxic to NPC, and did not interfere with NPC proliferation and differentiation. Labelled cells were then grafted into the brain after cerebral ischaemia, and imaged over four weeks using MRI. NPC migration was not observed in vivo, but an endogenous contrast evolved over time within the lesioned tissue, which presented a source of confounding signal for cell tracking. Endogenous ferric iron was observed in the lesion on histological sections. Several limitations of using MRI-based iron oxide contrast agents were highlighted in this study. To circumvent these limitations, we considered the development of gadolinium-based MRI contrast agents for cellular labeling and tracking, in collaboration with Imperial College chemistry department. Polymeric Gd-DOTA chelates were synthesized and designed for maximal r1 relaxivity, and their relaxivity and effects on cell viability were assessed. Through this approach, we identified a number of candidate polymeric Gd-DOTA chelates with high relaxivity and low cytotoxicity for use in cellular imaging and tracking studies. Next, cell tracking of endogenous NPC was investigated, using MRI contrast agent and transgenic lineage tracing approaches. A method of in situ labeling of endogenous NPC with the MRI contrast agent FePro was developed. NPC were labeled with FePro in situ, and their normal migration to the olfactory bulb, where they contribute to neurogenesis, could be imaged in vivo and ex vivo. In a second study, the migration of NPC constitutively expressing green fluorescent protein (GPF) under the promoters of genes of two developmentally distinct cortical and striatal NPC populations, was investigated following cerebral ischaemia. Both cortical and striatal populations of NPC were observed to contribute to the migrating streams of NPC that were observed in the striatum after five weeks post-ischaemia. These studies demonstrate that MRI contrast agents offer the potential for in vivo, longitudinal tracking of NPC migration, in both grafted and endogenous NPC populations. Coupled with transgenic lineage tracing, and used in animal models of CNS injury such as cerebral ischaemia, labeling and tracking the migration of NSC with MRI contrast agents can contribute to our understanding of NPC biology in pathological environments

Cellular Imaging and Emerging Technologies for Adult Neurogenesis Research

The first report on the generation of new neurons in the adult mammalian brain occurred in the early 1960s, however, nearly 40 years passed before the scientific community generally recognized the existence of adult mammalian neurogenesis. Development of new technologies that facilitate the identification of newborn neurons in the early 1990s has been central to expanding our understanding of adult neurogenesis as a process influencing mammalian brain plasticity. Subsequently, the field of adult neurogenesis progressed tremendously thanks to continuous technical advances allowing in vivo and in vitro manipulations of adult neural progenitors. Today, a core understanding of various aspects of adult neurogenesis has emerged, including neural progenitor proliferation and fate-specification, and the migration, maturation, and synaptic integration of newborn neurons into functional circuits. However, numerous questions remain open. This research topic issue gather

Tracking Neural Progenitor Cell Migration in the Rodent Brain Using Magnetic Resonance Imaging

The study of neurogenesis and neural progenitor cells (NPCs) is important across the biomedical spectrum, from learning about normal brain development and studying disease to engineering new strategies in regenerative medicine. In adult mammals, NPCs proliferate in two main areas of the brain, the subventricular zone (SVZ) and the subgranular zone, and continue to migrate even after neurogenesis has ceased within the rest of the brain. In healthy animals, NPCs migrate along the rostral migratory stream (RMS) from the SVZ to the olfactory bulb, and in diseased animals, NPCs migrate toward lesions such as stroke and tumors. Here we review how MRI-based cell tracking using iron oxide particles can be used to monitor and quantify NPC migration in the intact rodent brain, in a serial and relatively non-invasive fashion. NPCs can either be labeled directly in situ by injecting particles into the lateral ventricle or RMS, where NPCs can take up particles, or cells can be harvested and labeled in vitro, then injected into the brain. For in situ labeling experiments, the particle type, injection site, and image analysis methods have been optimized and cell migration toward stroke and multiple sclerosis lesions has been investigated. Delivery of labeled exogenous NPCs has allowed imaging of cell migration toward more sites of neuropathology, which may enable new diagnostic and therapeutic opportunities for as-of-yet untreatable neurological diseases

Adult neural stem/progenitor cells in response to their microenvironment : proliferation, differentiation, and migration

The plasticity of adult neural stem/progenitor cells allows a differential response to a variety of environmental cues. Over the past decade, significant research efforts have been devoted into understanding the regulation of neural stem/progenitor cells due to their promising potential for cell replacement therapies in adult neurological diseases. It has been demonstrated that after brain injury both endogenous and grafted neural stem/progenitor cells have the ability to proliferate to expand their number, migrate long distances to the lesioned site and differentiate into new specific neurons to replace the ones that have been lost. All these procedure are regulated by extrinsic cue found in the microenvironment surrounding the neural stem/progenitor cells. Several chemokines and growth factors have been identified that stimulate the proliferation, differentiation, and migration of endogenous or exogenous neural stem/progenitor cells. The first part of this dissertation work (Chapter 5) identifies the role of several extrinsic factors expressed and secreted by hippocampal astrocytes that regulate the neuronal differentiation of adult neural stem/progenitor cells in the neurogenic region of the dentate gyrus. While in non-neurogenic regions, astrocytes secrete factors that inhibit the differentiation of adult neural stem/progenitor cells. Cell migration is an essential component of neurogenesis in both embryonic and adult brains. Many critical signaling factors and molecules are involved in governing the dynamic process of cell migration, which includes chemotaxis, cytoskeleton restructuring, nuclear translocation, and extracellular matrix remodeling. Extracellular molecules regulate the interaction and communication of the cell with its microenvironment. Investigators have shown that extracellular matrix and matrix remodeling factors play a critical role in directing stem cell migration during development and in the response to brain injury. Identification of the molecular pathways and mechanisms of these factors, involved in regulating stem cell fate choice and homing into the damaged areas, is vital for new treatments in brain injury. In the second part of this dissertation (Chapter 6), I focus on demonstrating that several matrix metalloproteinases are demonstrated to play a role in both the migration and differentiation of adult neural stem cells/progenitor in response to stroke-induced chemokines. The role of matrix metalloproteinase in differentiation may be the first evidence of extracellular molecules effecting the intrinsic regulation of adult neural stem/progenitor fate choice

Detection of mouse endogenous type B astrocytes migrating towards brain lesions

16 p.-7 fig. Elvira G. et alt.Neuroblasts represent the predominant migrating cell type in the adult mouse brain. There are, however, increasing evidences of migration of other neural precursors. This work aims at identifying in vivo endogenous early neural precursors, different from neuroblasts, able to migrate in response to brain injuries. The monoclonal antibody Nilo1, which unequivocally identifies type B astrocytes and embryonic radial glia, was coupled to magnetic glyconanoparticles (mGNPs). Here we show that Nilo1-mGNPs in combination with magnetic resonance imaging in living mice allowed the in vivo identification of endogenous type B astrocytes at their niche, as well as their migration to the lesion site in response to glioblastoma, demyelination, cryolesion or mechanical injuries. In addition, Nilo1(+) adult radial glia-like structures were identified at the lesion site a few hours after damage. For all damage models used, type B astrocyte migration was fast and orderly. Identification of Nilo1(+) cells surrounding an induced glioblastoma was also possible after intraperitoneal injection of the antibody. This opens up the possibility of an early identification of the initial damage site(s) after brain insults, by the migration of type B astrocytes. Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.This work was supported by grants from the Instituto de Salud Carlos III (grant RD06/0010/1010 to JAGS), and the Ministry of Science and Innovation (grants SAF2009-07974 to JAGS, CTQ-2011-271268 to SP, AMIT, CENIT-CDTI to MD).Peer reviewe

Ann Biomed Eng

Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality ((1)H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10\uc2\ua0\uce\ubcL/10(4) cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by (1)H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast (1)H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.DP2 HD084067/HD/NICHD NIH HHS/United States1DP2HD084067/DP/NCCDPHP CDC HHS/United States2017-03-01T00:00:00Z26597417PMC479267

Long-Term Monitoring of Post-Stroke Plasticity After Transient Cerebral Ischemia in Mice Using In Vivo and Ex Vivo Diffusion Tensor MRI

We used a murine model of transient focal cerebral ischemia to study: 1) in vivo DTI long-term temporal evolution of the apparent diffusion coefficient (ADC) and diffusion fractional anisotropy (FA) at days 4, 10, 15 and 21 after stroke 2) ex vivo distribution of a plasticity-related protein (GAP-43) and its relationship with the ex vivo DTI characteristics of the striato-thalamic pathway (21 days)